Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012223

Director acquired 747 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2023-08-16 Other acquisition 10b5-1 +65 $1.64 $107 27,358 D
Jones James Director 2023-08-17 Other acquisition 10b5-1 +65 $1.70 $111 27,423 D
Jones James Director 2023-08-18 Other acquisition 10b5-1 +65 $1.70 $111 27,488 D
Jones James Director 2023-08-21 Other acquisition 10b5-1 +65 $1.68 $109 27,553 D
Jones James Director 2023-08-22 Other acquisition 10b5-1 +65 $1.72 $112 27,618 D
Jones James Director 2023-08-23 Other acquisition 10b5-1 +65 $1.70 $111 27,683 D
Jones James Director 2023-08-24 Other acquisition 10b5-1 +27 $1.69 $46 27,710 D
Jones James Director 2023-08-25 Other acquisition 10b5-1 +65 $1.70 $111 27,775 D
Jones James Director 2023-08-28 Other acquisition 10b5-1 +65 $1.71 $111 27,840 D
Jones James Director 2023-08-29 Other acquisition 10b5-1 +70 $1.67 $117 27,910 D
Jones James Director 2023-08-30 Other acquisition 10b5-1 +65 $1.68 $109 27,975 D
Jones James Director 2023-08-31 Other acquisition 10b5-1 +65 $1.67 $109 28,040 D
Loading xslF345X05/marketforms-62531.xml…